CalciMedica, Inc. 8-K

What Happened
CalciMedica, Inc. announced its financial results for the year ended December 31, 2025 in a press release issued March 3, 2026 and filed an 8-K (Item 2.02) to disclose those results. The press release is attached to the filing as Exhibit 99.1. The report was signed by CEO A. Rachel Leheny, Ph.D.

Key Details

• Filing date: March 3, 2026 (8-K reporting results of operations and financial condition).
• Press release dated March 3, 2026 attached as Exhibit 99.1.
• Report covers CalciMedica’s financial results for the year ended December 31, 2025.
• 8-K executed and signed by CEO A. Rachel Leheny, Ph.D.

Why It Matters
This 8-K signals that CalciMedica has publicly released its 2025 annual earnings and related financial information. Investors should review the attached press release to see revenue, net income/loss, cash position, and any management commentary or forward-looking statements. Also watch for the company’s forthcoming Form 10-K or other SEC filings for full audited financial statements and more detailed disclosures.